Substituent Effects of 2-Pyridones on Selective O-Arylation with Diaryliodonium Salts: Synthesis of 2-Aryloxypyridines under Transition­-Metal-Free Conditions

^‡ X.-H. Li and A.-H. Ye contributed equally to this work

Abstract

An efficient transition-metal-free strategy to synthesize 2-aryloxypyridine derivatives has been developed by a selective O-arylation of 2-pyridones with diaryliodonium salts. The reaction was compatible with a series of functional groups for 2-pyridones and diaryliodonium salts such as halides, nitro, cyano, and ester groups. The substituents at the C6-position of 2-pyridones favored O-arylation products because of steric hindrance. The reaction was easily performed on a gram-scale and 6-chloro-2-pyridone was a good precursor to access various unsubstituted 2-aryloxypyridines by dehalogenation. A P2Y₁ lead compound analogue could be prepared in good yield over two steps.

Key words

aryloxypyridine - diaryliodonium salt - O-arylation - 2-pyridone - substituent effects

• References

• 1a Caron S. Do NM. Sieser JE. Whritenour DC. Hill PD. Org. Process Res. Dev. 2009; 13: 324
• 1b Hu E. Kunz RK. Chen N. Rumfelt S. Siegmund A. Andrews K. Chmait S. Zhao S. Davis C. Chen H. Lester-Zeiner D. Ma J. Biorn C. Shi J. Porter A. Treanor J. Allen JR. J. Med. Chem. 2013; 56: 8781
• 1c Rowbottom MW. Bain G. Calderon I. Lasof T. Lonergan D. Lai A. Huang F. Darlington J. Prodanovich P. Santini AM. King CD. Goulet L. Shannon KE. Ma GL. Ngugen K. Mackenna DA. Evans JF. Hutchinson JH. J. Med. Chem. 2017; 60: 4403
• 1d Chao H. Turdi H. Herpin TF. Roberge JY. Liu Y. Schnur DM. Poss MA. Rehfuss R. Hua J. Wu Q. Price LA. Abell LM. Schumacher WA. Bostwick JS. Steinbacher TE. Stewart AB. Ogletree ML. Huang CS. Chang M. Cacace AM. Arcuri MJ. Celani D. Wexler RR. Lawrence RM. J. Med. Chem. 2013; 56: 1704
• 1e Duan H. Ning M. Chen X. Zou Q. Zhang L. Feng Y. Zhang L. Leng Y. Shen J. J. Med. Chem. 2012; 55: 10475

For selected examples for preparation of 2-aryloxypyridines, see:
• 2a Takise R. Isshiki R. Muto K. Itami K. Yamaguchi J. J. Am. Chem. Soc. 2017; 139: 3340
• 2b Hosseini-Sarvari M. Razmi Z. RSC Adv. 2014; 4: 44105
• 2c Cherng Y.-J. Tetrahedron 2002; 58: 887
• 2d Platon M. Cui L. Mom S. Richard P. Saeys M. Hierso J.-C. Adv. Synth. Catal. 2011; 353: 3403
• 2e Ghatak A. Khan S. Roy R. Bhar S. Tetrahedron Lett. 2014; 55: 7082
• 2f Zhang Q. Wang D. Wang X. Ding K. J Org. Chem. 2009; 74: 7187
• 2g D’Angelo ND. Peterson JJ. Booker SK. Fellows I. Dominguez C. Hungate R. Reider PJ. Kim T.-S. Tetrahedron Lett. 2006; 47: 5045
• 2h Lloung M. Loupy A. Marque S. Petit A. Heterocycles 2004; 63: 297

For selected examples for modification of 2-aryloxypyridines, see:
• 3a Zhang C. Sun P. J. Org. Chem. 2014; 79: 8457
• 3b Xu Y. Liu P. Li S.-L. Sun P. J. Org. Chem. 2015; 80: 1269
• 3c Chu J.-H. Lin P-S. Wu M.-J. Organometallics 2010; 29: 4058
• 3d Lou S.-J. Chen Q. Wang Y.-F. Xu D.-Q. Du X.-H. He J.-Q. Mao Y.-J. Xu Z.-Y. ACS Catal. 2015; 5: 2846
• 3e McAteer DC. Javed E. Huo L. Huo S. Org. Lett. 2017; 19: 1606
• 3f Kaida H. Goya T. Nishi Y. Hirano K. Satoh T. Miura M. Org. Lett. 2017; 19: 1236

For selected examples of N-arylation of 2-pyridones, see:
• 4a Mederski WW. K. R. Lefort M. Germann M. Kux D. Tetrahedron 1999; 55: 12757
• 4b Lam PY. S. Clark CG. Sauber S. Adams J. Averill KM. Chan DM. T. Combs A. Synlett 2000; 674
• 4c Altman RA. Buchwald SL. Org. Lett. 2007; 9: 643
• 4d Li CS. Dixon DD. Tetrahedron Lett. 2004; 45: 4257
• 4e Chen T. Luo Y. Hu Y. Yang B. Lu W. Eur. J. Med. Chem. 2013; 64: 613
• 4f Crifar C. Petiot P. Ahmad T. Gagnon A. Chem. Eur. J. 2014; 20: 2755
• 4g Lam PY. S. Vincent G. Bonne D. Clark CG. Tetrahedron Lett. 2002; 43: 3091

For selected examples of O-arylation of 2-pyridones, see:
• 5a Chen T. Huang Q. Luo Y. Hu Y. Lu W. Tetrahedron Lett. 2013; 54: 1401
• 5b Cristau H.-J. Cellier PP. Spindler J.-F. Taillefer M. Chem. Eur. J. 2004; 10: 5607

For some recent reviews for diaryliodonium salts, see:
• 6a Merritt EA. Olofsson B. Angew. Chem. Int. Ed. 2009; 48: 9052
• 6b Merritt EA. Olofsson B. Synthesis 2011; 517
• 6c Olofsson B. Top. Curr. Chem. 2015; 373: 135
• 6d Aradi K. Tóth BL. Tolnai GL. Novák Z. Synlett 2016; 27: 1456
• 6e Fañanás-Mastral M. Synthesis 2017; 49: 1905
• 6f Wang X. Studer A. Acc. Chem. Res. 2017; 50: 1712

For selected examples, see:
• 7a Lindstedt E. Stridfeldt E. Olofsson B. Org. Lett. 2016; 18: 4234
• 7b Sasaki T. Miyagi K. Moriyama K. Togo H. Org. Lett. 2016; 18: 944
• 7c Sheng J. Su X. Cao C. Chen C. Org. Chem. Front. 2016; 3: 501
• 7d Seidl TL. Sundalam SK. McCullough B. Stuart DR. J. Org. Chem. 2016; 81: 1998
• 7e Mehra MK. Tantak MP. Kumar I. Kumar D. Synlett 2016; 27: 604
• 7f Bihari T. Baninszki B. Gonda Z. Kovacs S. Novák Z. Stirling A. J. Org. Chem. 2016; 81: 5417
• 7g Qi C. Guo T. Xiong W. Wang L. Jiang H. ChemistrySelect 2017; 2: 4691
• 7h Mehra MK. Tantak MP. Arun V. Kumar I. Kumar D. Org. Biomol. Chem. 2017; 15: 4956
• 7i Tinnis F. Stridfeldt E. Lundberg H. Adolfosson H. Olofsson B. Org. Lett. 2015; 17: 2688
• 7j Gonda Z. Novak Z. Chem. Eur. J. 2015; 21: 16801
• 7k Riedmueller S. Nachtsheim BJ. Synlett 2015; 26: 651
• 7l Gao HY. Xu QL. Keene C. Kürti L. Chem. Eur. J. 2014; 20: 8883
• 7m Ghosh R. Stridfeldt E. Olofsson B. Chem. Eur. J. 2014; 20: 8888
• 7n Li P. Cheng G. Zhang H. Xu X. Gao J. Cui X. J. Org. Chem. 2014; 79: 8156
• 7o Ghosh R. Olofsson B. Org. Lett. 2014; 16: 1830
• 7p Castro LC. M. Chatani N. Synthesis 2014; 46: 2312
• 7q Yang Y. Wu X. Han J. Mao S. Qian X. Wang L. Eur. J. Org. Chem. 2014; 6854
• 8 Jung S.-H. Sung D.-B. Park C.-H. Kim W.-S. J. Org. Chem. 2016; 81: 7717

For recent reviews on compounds containing an N–O bond, see:
• 9a Jiao Y.-X. Ma X.-P. Su G.-F. Mo D.-L. Synthesis 2017; 49: 933
• 9b Tabolin AA. Ioffe SL. Chem. Rev. 2014; 114: 5426
• 9c Bolotin DS. Bokach NA. Demakova MY. Kukushkin VY. Chem. Rev. 2017; 117: 13039

For some examples of arylation of N−O bond by diaryliodonium salts in our group, see:
• 10a Ma X.-P. Shi W.-M. Mo X.-L. Li X.-H. Li L.-G. Pan C.-X. Chen B. Su G.-F. Mo D.-L. J. Org. Chem. 2015; 80: 10098
• 10b Shi W.-M. Ma X.-P. Pan C.-X. Su G.-F. Mo D.-L. J. Org. Chem. 2015; 80: 11175
• 10c Li X.-H. Li L.-G. Mo X.-L. Mo D.-L. Synth. Commun. 2016; 46: 963
• 10d Wang Z.-X. Shi W.-M. Bi H.-Y. Li X.-H. Su G.-F. Mo D.-L. J. Org. Chem. 2016; 81: 8014
• 10e Wu S.-Y. Ma X.-P. Liang C. Mo D.-L. J. Org. Chem. 2017; 82: 3232
• 10f Shi W.-M. Li X.-H. Liang C. Mo D.-L. Adv. Synth. Catal. 2017; 359: 4129

For pK _a data, see:
• 11a Bordwell FG. Bartmess JE. Hautala JA. J. Org. Chem. 1978; 43: 3095
• 11b Olmstead WM. Margolin Z. Bordwell FG. J. Org. Chem. 1980; 45: 3295
• 11c Bordwell FG. Drucker GE. Fried HE. J. Org. Chem. 1981; 46: 632
• 11d Bordwell FG. Ji GZ. J. Am. Chem. Soc. 1991; 113: 8398
• 12a Dosanjh A. Eur. J. Pharmacol. 2006; 536: 219
• 12b du Bois RM. Nat. Rev. Drug Discovery 2010; 9: 129
• 12c Richeldi L. Yasothan U. Kirkpatrick P. Nat. Rev. Drug Discovery 2011; 10: 489
• 13 Magee TV. Brown MF. Starr JT. Ackley DC. Abramite JA. Aubrecht J. Butler A. Crandon JL. Dib-Hajj F. Flanagan ME. Granskog K. Hardink JR. Huband MD. Irvine R. Kuhn M. Leach KL. Li B. Lin J. Luke DR. Macvane SH. Miller AA. McCurdy S. McKim JM. Jr. Nicolau DP. Nguyen T.-T. Noe MC. O’Donnell JP. Seibel SB. Shen Y. Stepan AF. Tomaras AP. Wilga PC. Zhang L. Xu J. Chen JM. J. Med. Chem. 2013; 56: 5079
• 14 For DFT calculations about the tautomers of 2-pyridone and 2-hydroxypyridine, see: Michelson AZ. Petronico A. Lee JK. J. Org. Chem. 2012; 77: 1623
• 15 For reductive elimination or 1,2-aryl migrations of iodonium salts, see: Malmgren J. Santoro S. Jalajian N. Himo F. Olofsson B. Chem. Eur. J. 2013; 19: 10334
• 16a Bielawski M. Zhu M. Olofsson B. Adv. Synth. Catal. 2007; 349: 2610
• 16b Bielawski M. Olofsson B. Chem. Commun. 2007; 2521
• 17 For the dehalogenation procedure, see: Nohara A. Ishiguro T. Ukawa K. Sugihara H. Maki Y. Sanno Y. J. Med. Chem. 1985; 28: 559
• 18 Janssens R. Communi D. Pirotton S. Samson M. Parmentier M. Boeynaems JM. Biochem. Biophys. Res. Commun. 1996; 221: 588
• 19 Lv X. Bao W. J. Org. Chem. 2007; 72: 3863
• 20 Li J. Yang Y. Wang Z. Feng B. You J. Org. Lett. 2017; 19: 3083
• 21 Sugahara M. Ukita T. Chem. Pharm. Bull. 1997; 45: 719
• 22 Yang Y. Huang H. Wu L. Liang Y. Org. Biomol. Chem. 2014; 12: 5351
• 23 Wawzonek S. Van Truong T. J. Heterocycl. Chem. 1988; 25: 381
• 24 Li Y. Xie F. Li X. J. Org. Chem. 2016; 81: 715
• 25 Corte JR. Fang T. Pinto DJ. P. Han W. Hu Z. Jiang X.-J. Li Y.-L. Gauuan JF. Hadden M. Orton D. Rendina AR. Luettgen JM. Bioorg. Med. Chem. Lett. 2008; 18: 2845
• 26 Krug M. Erlenkamp G. Sippl W. Schächtele C. Totzke F. Hilgeroth A. Bioorg. Med. Chem. Lett. 2010; 20: 6915
• 27 Liu Q. Lu Z. Ren W. Shen K. Wang Y. Xu Q. Chin. J. Chem. 2013; 31: 764
• 28 Stocks MJ. Barber S. Ford R. Leroux F. St-Gallay S. Teague S. Xue Y. Bioorg. Med. Chem. Lett. 2005; 15: 3459
• 29 Kuzuya M. Noguchi A. Kamiya S. Okuda T. Chem. Pharm. Bull. 1985; 33: 2313
• 30 Guan A. Liu C. Chen W. Yang F. Xie Y. Zhang J. Li Z. Wang M. J. Agric. Food Chem. 2017; 65: 1272
• 31 Sheehan JC. Daves GD. Jr. J. Org. Chem. 1965; 30: 3247
• 32 Chan L. McNally A. Toh QY. Mendoza A. Gaunt MJ. Chem. Sci. 2015; 6: 1277
• 33 Kinuta H. Tobisu M. Chatani N. J. Am. Chem. Soc. 2015; 137: 1593
• 34 Hartshorn CM. Steel PJ. Angew. Chem. Int. Ed. 1996; 35: 2655